跳至主要内容
临床试验/CTRI/2025/02/079921
CTRI/2025/02/079921尚未招募3 期

A Randomized Controlled Clincal Study On Role Of Darvyadia Syrup In Pittaj Mutrakruchha WSR Urinary Tract Infection In Age Group Of 6 Years to 12 Years.

Shree Saptashrungi Ayurved Mahavidyalay1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2025年2月14日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
140
试验地点
1
主要终点
Reduce in sign and symptoms of pittaj mutrakruccha.

研究概览

简要总结

  1. Primary Objective

To study the effect of Darvyadi Syrup in Pittajmutrakrichha in age

group of 6yrs to 12yrs

  1. Secondary Objective
  1. To study the literature of pittaj mutrakrichha accordingto

classical Ayurveda texts. 2) To study the Urinary tract infection from modern literature. 3)To compare the effects of Darvyadi Syrup in Pittajmutrakrichha

against control drug Disodium Hydrogen citrate.

PARTICIPANTS

140 patients diagnosed with urinary tract infection meeting inclusion and exclusion criteria from OPD and IPD of department of kaumarbhritya of Shree Saptashrungi Medical College and Hospital

Nashik.

Interventions 70 patients Darvyadi syrup: Administered according to standardized protocol.

70 patients Disodium hydrogen citrate : Administered according to standardized protocol.

Primary Outcome : Reduce the sign and symptoms of pittaj mutrakruccha

Secondary Outcome: No recurrency of pittaj mutrakruccha Treatment

Duration : 7 Days Follow Up :1st , 5th , 7th Days

Data Analysis : Data will be analysed using appropriate statistical methods to compare the effectiveness of the intervension on the primary and secondary outcomes.

Ethical Considerations : The study will be conducted in accordance with ethical guidelines and with informed consent from participents.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
6.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Age group between 6yrs to 12 yrs.
  • Patients irrespective of religion,sex,and economicalstatus.
  • Patients with sign and symptomsof acute onset of Pittaj mutrakruchha.

排除标准

  • Below the age of 6yrs and above the age of 12yrs.
  • Congenital abnormalities.Patient having serious illness ,severe kidney diseases Obstructive Pathologies Patient having infectious pathology ● Chronic UTI pathology urinaryneurologicalsymptoms ● Any othersystemic illness.

结局指标

主要结局

Reduce in sign and symptoms of pittaj mutrakruccha.

时间窗: Reduce in sign and symptoms of pittaj mutrakruccha after 1 week to 2 weeks.

次要结局

  • No recurrence of pittaj mutrkruccha(7 days)

研究者

发起方
Shree Saptashrungi Ayurved Mahavidyalay
申办方类型
Other [Private Ayurved College ]
责任方
Principal Investigator
主要研究者

Dr Siddhesh Rajendra Shete

Shree Saptashrungi Ayurved Mahavidyalaya

研究点 (1)

Loading locations...

相似试验